Source Pravda.Ru

Sanofi-Aventis to Buy Chattem - Comments

Monday Moody's Investors Service said it placed ratings for Chattem Inc. on review for a possible upgrade, which follows the company's announcement it is being bought for $1.9 billion by French drug developer Sanofi-Aventis SA.

Show more